33
Participants
Start Date
February 28, 2010
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
"GLP-1 at a rate of 1.2 pmol/kg/min~Regadenoson as a stress agent 0.4mg IV given during MCE~Definity:0.6 ml of Definity diluted with 30ml of 0.9% saline infused by SYRINGE Infusion Pump"
Mayo Clinic, Rochester
Lead Sponsor
Collaborators (1)
University of Nebraska
OTHER
Astellas Pharma US, Inc.
INDUSTRY
Lantheus Medical Imaging
INDUSTRY
Mayo Clinic
OTHER